Operating Profit Cambio Fecha
AbbVie USD 3.2B 914M 2023-12
Acorda Therapeutics USD -3632000 7.84M 2023-06
Agios Pharmaceuticals USD -106277000 5.38M 2023-12
ALKERMES USD 43.85M 195.34M 2023-09
Alnylam Pharmaceuticals USD -116404000 330.27M 2023-12
Amgen USD 1.27B 819M 2023-12
Biogen USD 358.9M 200.1M 2023-12
BioMarin Pharmaceutical USD 14.22M 11.44M 2023-12
Bluebird Bio USD -84729000 568K 2023-09
Bristol-Myers Squibb USD 1.85B 473M 2023-12
Eli Lilly USD 2.39B 1.94B 2023-12
Gilead Sciences USD 1.61B 1.01B 2023-12
GlaxoSmithKline GBP 1.95B 192M 2023-09
Incyte USD 187.27M 27.44M 2023-12
J&J USD 4.83B 391M 2023-12
Merck USD -1933000000 7.68B 2023-12
Moderna USD 6M 2.02B 2023-12
Neurocrine Biosciences USD 141.2M 67.6M 2023-09
Pfizer USD -6551000000 3.61B 2023-12
PTC Therapeutics USD -131738000 13.57M 2023-12
Regeneron Pharmaceuticals USD 972.9M 138.1M 2023-12
Sarepta Therapeutics USD -48342000 16.82M 2023-09
United Therapeutics USD 260.1M 66.9M 2023-12
Vertex Pharmaceuticals USD 1.04B 11.7M 2023-09



Gilead Sciences Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2024.